NO20055170L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number
NO20055170L
NO20055170L NO20055170A NO20055170A NO20055170L NO 20055170 L NO20055170 L NO 20055170L NO 20055170 A NO20055170 A NO 20055170A NO 20055170 A NO20055170 A NO 20055170A NO 20055170 L NO20055170 L NO 20055170L
Authority
NO
Norway
Prior art keywords
organic compounds
ceramide
desoxyascomycin
epichloro
xerosis
Prior art date
Application number
NO20055170A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055170D0 (no
Inventor
Maximillan Grassberger
Stefan Hirsch
Anton Stuetz
Nabila Sekkat
Karl Friedrich Mayer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055170D0 publication Critical patent/NO20055170D0/no
Publication of NO20055170L publication Critical patent/NO20055170L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20055170A 2003-04-04 2005-11-03 Organiske forbindelser NO20055170L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307867.2A GB0307867D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003514 WO2004087202A2 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising a macrolide immunomodulator

Publications (2)

Publication Number Publication Date
NO20055170D0 NO20055170D0 (no) 2005-11-03
NO20055170L true NO20055170L (no) 2006-01-04

Family

ID=9956230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055170A NO20055170L (no) 2003-04-04 2005-11-03 Organiske forbindelser

Country Status (12)

Country Link
US (2) US20070021377A1 (enExample)
EP (1) EP1638558A2 (enExample)
JP (1) JP2006522060A (enExample)
CN (1) CN1764455A (enExample)
BR (1) BRPI0409169A (enExample)
CA (1) CA2519958A1 (enExample)
GB (1) GB0307867D0 (enExample)
IS (1) IS8103A (enExample)
MX (1) MXPA05010704A (enExample)
NO (1) NO20055170L (enExample)
RS (1) RS20050723A (enExample)
WO (1) WO2004087202A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
CN120754078A (zh) * 2024-07-30 2025-10-10 中山大学 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
FR2710527B1 (fr) * 1993-09-30 1995-12-08 Roussel Uclaf Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
EP0786986B1 (en) * 1994-10-26 2002-03-20 Novartis AG Use of an unsaturated fatty alcohol
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
AU749623B2 (en) * 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
GB0200429D0 (en) * 2002-01-09 2002-02-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN1764455A (zh) 2006-04-26
CA2519958A1 (en) 2004-10-14
EP1638558A2 (en) 2006-03-29
JP2006522060A (ja) 2006-09-28
US20080132534A1 (en) 2008-06-05
NO20055170D0 (no) 2005-11-03
GB0307867D0 (en) 2003-05-14
MXPA05010704A (es) 2005-12-12
BRPI0409169A (pt) 2006-04-11
WO2004087202A3 (en) 2005-02-03
US20070021377A1 (en) 2007-01-25
AU2004226822A1 (en) 2004-10-14
IS8103A (is) 2005-10-31
RS20050723A (sr) 2007-11-15
WO2004087202A2 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
NO20081041L (no) PPar aktive forbindelser
NO20055136L (no) Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer
EP1266959A3 (en) Devices and method for cell harvesting
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
UY30468A1 (es) Compuestos quimicos.
NO20081067L (no) Behandling med dihydropyndinkalsiumkanalblokkere og omega 3-fettsyrer, og et kombinasjonsprodukt derav
WO2008003007A3 (en) Compositions and methods for treating parasitic infections
CR11339A (es) Combinaciones que comprenden una cepa fungicida y un compuesto activo
WO2004052177A3 (en) Cell-based therapies for ischemia
AU2011202385A1 (en) Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
BRPI0818366A2 (pt) Composto, pró-droga, medicamento, método inibidor de faah, métodos de profilaxia ou tratamento para ansiedade, ou depressão, ou de alívio da dor, e de profilaxia ou tratamento para dor inflamatória ou dor neuropática, e, uso do composto.
WO2006075330A3 (en) Methods and pharmaceutical compositions useful for treating psoriasis
NO20072290L (no) Organiske forbindelser.
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
NO20092134L (no) Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser
NO20055170L (no) Organiske forbindelser
ATE411279T1 (de) Arylsulfonamidobenzylverbindungen
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2009068682A3 (en) Phenyl-oxetanyl-derivatives
WO2005092924A8 (en) Rab9a, rab11a, and modulators thereof related to infectious disease
NO20055137L (no) Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer
UY29532A1 (es) Derivados del ácido 6,7-dihidro-5h-imidazo(1,2-a)imidazol-3-sulfónico

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application